NEW YORK (GenomeWeb News) – Gene expression company Genometry has raised $3 million in a Series A equity round of funding.

Genometry President and CEO Justin Lamb said that the funds will go toward establishing its operations and running the business. According to the company's Form D filed with the US Securities and Exchange Commission, the round had 11 investors. Lamb declined to identify the investors in the round but said they comprise venture firms, private equity firms, and a corporate strategic investor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.